Exact Mass: 511.2482
Exact Mass Matches: 511.2482
Found 500 metabolites which its exact mass value is equals to given mass value 511.2482
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Cerebrocrast
Bis(2-propoxyethyl) 4-[2-(difluoromethoxy)phenyl]-2,6-dimethyl-3,4-dihydropyridine-3,5-dicarboxylate
Ile His Asn Glu
Gln His Val Glu
Ser Tyr Lys Asp
His Ala Arg Glu
Ile Asn His Glu
verruculogen
An organic heterohexacyclic compound that is a mycotoxic indole alkaloid isolated from Penicillium and Aspergillus species. CONFIDENCE Penicillium amphipolaria
Ala Glu His Arg
Ala Glu Arg His
Ala Phe Phe Gln
Ala Phe Gln Phe
Ala His Glu Arg
Ala His Arg Glu
Ala His Val Trp
Ala His Trp Val
Ala Lys Met Tyr
Ala Lys Tyr Met
Ala Met Lys Tyr
Ala Met Tyr Lys
Ala Gln Phe Phe
Ala Arg Glu His
Ala Arg His Glu
Ala Val His Trp
Ala Val Trp His
Ala Trp His Val
Ala Trp Val His
Ala Tyr Lys Met
Ala Tyr Met Lys
Cys His Pro Arg
Cys His Arg Pro
Cys Lys Val Tyr
Cys Lys Tyr Val
Cys Pro His Arg
Cys Pro Arg His
Cys Arg His Pro
Cys Arg Pro His
Cys Val Lys Tyr
Cys Val Tyr Lys
Cys Tyr Lys Val
Cys Tyr Val Lys
Asp His Ile Gln
Asp His Leu Gln
Asp His Gln Ile
Asp His Gln Leu
Asp Ile His Gln
Asp Ile Gln His
Asp Lys Ser Tyr
Asp Lys Tyr Ser
Asp Leu His Gln
Asp Leu Gln His
Asp Gln His Ile
Asp Gln His Leu
Asp Gln Ile His
Asp Gln Leu His
Asp Ser Lys Tyr
Asp Ser Tyr Lys
Asp Tyr Lys Ser
Asp Tyr Ser Lys
Glu Ala His Arg
Glu Ala Arg His
Glu His Ala Arg
Glu His Ile Asn
Glu His Leu Asn
Glu His Asn Ile
Glu His Asn Leu
Glu His Gln Val
Glu His Arg Ala
Glu His Val Gln
Glu Ile His Asn
Glu Ile Asn His
Glu Leu His Asn
Glu Leu Asn His
Glu Asn His Ile
Glu Asn His Leu
Glu Asn Ile His
Glu Asn Leu His
Glu Gln His Val
Glu Gln Val His
Glu Arg Ala His
Glu Arg His Ala
Glu Val His Gln
Glu Val Gln His
Phe Ala Phe Gln
Phe Ala Gln Phe
Phe Phe Ala Gln
Phe Phe Gln Ala
Phe Lys Met Ser
Phe Lys Ser Met
Phe Met Lys Ser
Phe Met Ser Lys
Phe Gln Ala Phe
Phe Gln Phe Ala
Phe Ser Lys Met
Phe Ser Met Lys
Gly His Ile Trp
Gly His Leu Trp
Gly His Trp Ile
Gly His Trp Leu
Gly Ile His Trp
Gly Ile Trp His
Gly Leu His Trp
Gly Leu Trp His
Gly Trp His Ile
Gly Trp His Leu
Gly Trp Ile His
Gly Trp Leu His
His Ala Glu Arg
His Ala Val Trp
His Ala Trp Val
His Cys Pro Arg
His Cys Arg Pro
His Asp Ile Gln
His Asp Leu Gln
His Asp Gln Ile
His Asp Gln Leu
His Glu Ala Arg
His Glu Ile Asn
His Glu Leu Asn
His Glu Asn Ile
His Glu Asn Leu
His Glu Gln Val
His Glu Arg Ala
His Glu Val Gln
His Gly Ile Trp
His Gly Leu Trp
His Gly Trp Ile
His Gly Trp Leu
His Ile Asp Gln
His Ile Glu Asn
His Ile Gly Trp
His Ile Asn Glu
His Ile Gln Asp
His Ile Trp Gly
His Lys Met Pro
His Lys Asn Asn
His Lys Pro Met
His Leu Asp Gln
His Leu Glu Asn
His Leu Gly Trp
His Leu Asn Glu
His Leu Gln Asp
His Leu Trp Gly
His Met Lys Pro
His Met Pro Lys
His Asn Glu Ile
His Asn Glu Leu
His Asn Ile Glu
His Asn Lys Asn
His Asn Leu Glu
His Asn Asn Lys
His Pro Cys Arg
His Pro Lys Met
His Pro Met Lys
His Pro Arg Cys
His Gln Asp Ile
His Gln Asp Leu
His Gln Glu Val
His Gln Ile Asp
His Gln Leu Asp
His Gln Val Glu
His Arg Ala Glu
His Arg Cys Pro
His Arg Glu Ala
His Arg Pro Cys
His Val Ala Trp
His Val Glu Gln
His Val Gln Glu
His Val Trp Ala
His Trp Ala Val
His Trp Gly Ile
His Trp Gly Leu
His Trp Ile Gly
His Trp Leu Gly
His Trp Val Ala
Ile Asp His Gln
Ile Asp Gln His
Ile Glu His Asn
Ile Glu Asn His
Ile Gly His Trp
Ile Gly Trp His
Ile His Asp Gln
Ile His Glu Asn
Ile His Gly Trp
Ile His Gln Asp
Ile His Trp Gly
Ile Asn Glu His
Ile Gln Asp His
Ile Gln His Asp
Ile Trp Gly His
Ile Trp His Gly
Lys Ala Met Tyr
Lys Ala Tyr Met
Lys Cys Val Tyr
Lys Cys Tyr Val
Lys Asp Ser Tyr
Lys Asp Tyr Ser
Lys Phe Met Ser
Lys Phe Ser Met
Lys His Met Pro
Lys His Asn Asn
Lys His Pro Met
Lys Met Ala Tyr
Lys Met Phe Ser
Lys Met His Pro
Lys Met Pro His
Lys Met Ser Phe
Lys Met Tyr Ala
Lys Asn His Asn
Lys Asn Asn His
Lys Pro His Met
Lys Pro Met His
Lys Ser Asp Tyr
Lys Ser Phe Met
Lys Ser Met Phe
Lys Ser Tyr Asp
Lys Thr Thr Tyr
Lys Thr Tyr Thr
Lys Val Cys Tyr
Lys Val Tyr Cys
Lys Tyr Ala Met
Lys Tyr Cys Val
Lys Tyr Asp Ser
Lys Tyr Met Ala
Lys Tyr Ser Asp
Lys Tyr Thr Thr
Lys Tyr Val Cys
Leu Asp His Gln
Leu Asp Gln His
Leu Glu His Asn
Leu Glu Asn His
Leu Gly His Trp
Leu Gly Trp His
Leu His Asp Gln
Leu His Glu Asn
Leu His Gly Trp
Leu His Asn Glu
Leu His Gln Asp
Leu His Trp Gly
Leu Asn Glu His
Leu Asn His Glu
Leu Gln Asp His
Leu Gln His Asp
Leu Trp Gly His
Leu Trp His Gly
Met Ala Lys Tyr
Met Ala Tyr Lys
Met Phe Lys Ser
Met Phe Ser Lys
Met His Lys Pro
Met His Pro Lys
Met Lys Ala Tyr
Met Lys Phe Ser
Met Lys His Pro
Met Lys Pro His
Met Lys Ser Phe
Met Lys Tyr Ala
Met Pro His Lys
Met Pro Lys His
Met Ser Phe Lys
Met Ser Lys Phe
Met Tyr Ala Lys
Met Tyr Lys Ala
Asn Glu His Ile
Asn Glu His Leu
Asn Glu Ile His
Asn Glu Leu His
Asn His Glu Ile
Asn His Glu Leu
Asn His Ile Glu
Asn His Lys Asn
Asn His Leu Glu
Asn His Asn Lys
Asn Ile Glu His
Asn Ile His Glu
Asn Lys His Asn
Asn Lys Asn His
Asn Leu Glu His
Asn Leu His Glu
Asn Asn His Lys
Asn Asn Lys His
Pro Cys His Arg
Pro Cys Arg His
Pro His Cys Arg
Pro His Lys Met
Pro His Met Lys
Pro His Arg Cys
Pro Lys His Met
Pro Lys Met His
Pro Met His Lys
Pro Met Lys His
Pro Arg Cys His
Pro Arg His Cys
Gln Ala Phe Phe
Gln Asp His Ile
Gln Asp His Leu
Gln Asp Ile His
Gln Asp Leu His
Gln Glu His Val
Gln Glu Val His
Gln Phe Ala Phe
Gln Phe Phe Ala
Gln His Asp Ile
Gln His Asp Leu
Gln His Glu Val
Gln His Ile Asp
Gln His Leu Asp
Gln Ile Asp His
Gln Ile His Asp
Gln Leu Asp His
Gln Leu His Asp
Gln Thr Thr Tyr
Gln Thr Tyr Thr
Gln Val Glu His
Gln Val His Glu
Gln Tyr Thr Thr
Arg Ala Glu His
Arg Ala His Glu
Arg Cys His Pro
Arg Cys Pro His
Arg Glu Ala His
Arg Glu His Ala
Arg His Ala Glu
Arg His Cys Pro
Arg His Glu Ala
Arg His Pro Cys
Arg Pro Cys His
Arg Pro His Cys
Arg Ser Ser Tyr
Arg Ser Tyr Ser
Arg Tyr Ser Ser
Ser Asp Lys Tyr
Ser Phe Lys Met
Ser Phe Met Lys
Ser Lys Phe Met
Ser Lys Met Phe
Ser Met Phe Lys
Ser Met Lys Phe
Ser Arg Ser Tyr
Ser Arg Tyr Ser
Ser Ser Arg Tyr
Ser Ser Tyr Arg
Ser Tyr Arg Ser
Ser Tyr Ser Arg
Thr Lys Thr Tyr
Thr Lys Tyr Thr
Thr Thr Lys Tyr
Thr Thr Tyr Lys
Thr Tyr Lys Thr
Thr Tyr Thr Lys
Val Ala His Trp
Val Ala Trp His
Val Cys Lys Tyr
Val Cys Tyr Lys
Val Glu His Gln
Val Glu Gln His
Val His Ala Trp
Val His Glu Gln
Val His Gln Glu
Val His Trp Ala
Val Lys Cys Tyr
Val Lys Tyr Cys
Val Gln Glu His
Val Gln His Glu
Val Trp Ala His
Val Trp His Ala
Val Tyr Cys Lys
Val Tyr Lys Cys
Trp Ala His Val
Trp Ala Val His
Trp Gly His Ile
Trp Gly His Leu
Trp Gly Ile His
Trp Gly Leu His
Trp His Ala Val
Trp His Gly Ile
Trp His Gly Leu
Trp His Ile Gly
Trp His Leu Gly
Trp His Val Ala
Trp Ile Gly His
Trp Ile His Gly
Trp Leu Gly His
Trp Leu His Gly
Trp Val Ala His
Trp Val His Ala
Tyr Ala Lys Met
Tyr Ala Met Lys
Tyr Cys Lys Val
Tyr Cys Val Lys
Tyr Lys Ala Met
Tyr Lys Cys Val
Tyr Lys Asp Ser
Tyr Lys Met Ala
Tyr Lys Ser Asp
Tyr Lys Thr Thr
Tyr Lys Val Cys
Tyr Met Ala Lys
Tyr Met Lys Ala
Tyr Gln Thr Thr
Tyr Arg Ser Ser
Tyr Ser Asp Lys
Tyr Ser Lys Asp
Tyr Ser Arg Ser
Tyr Ser Ser Arg
Tyr Thr Lys Thr
Tyr Thr Gln Thr
Tyr Thr Thr Lys
Tyr Thr Thr Gln
Tyr Val Cys Lys
Tyr Val Lys Cys
Litronesib
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C273 - Antimitotic Agent
(1S)-2-oxobornane-10-sulphonic acid, compound with 7-[2-(diethylamino)ethyl]-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione (1:1)
1,3,5-Triazine, 2,4-diphenyl-6-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)[1,1-biphenyl]-3-yl]-
[(2R,3S,4S,5R,6S)-4-amino-6-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2S,3R,5S,6R)-3-amino-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-3,5-dihydroxyoxan-2-yl]methyl carbamate
6-[(2R,5R)-3-hydroxy-5-[4-[[(2R)-2-hydroxy-2-(4-hydroxyphenyl)ethyl]amino]-4-oxobutanoyl]oxy-6-methyloxan-2-yl]oxyheptanoic acid
N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-5-(oxane-4-carbonyl)-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-5-[4-oxanyl(oxo)methyl]-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-5-(oxane-4-carbonyl)-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
N-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-5-(oxane-4-carbonyl)-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-5-(oxane-4-carbonyl)-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-5-[4-oxanyl(oxo)methyl]-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-5-[4-oxanyl(oxo)methyl]-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
(2R)-2-[(4R,5R)-5-[[cyclopentylmethyl(methyl)amino]methyl]-4-methyl-1,1-dioxo-8-[2-(3-pyridinyl)ethynyl]-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
N-[(4R,7R,8R)-5-[(2-fluorophenyl)-oxomethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
N-[(4S,7S,8R)-5-[(2-fluorophenyl)-oxomethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
N-[(4R,7R,8S)-5-[(2-fluorophenyl)-oxomethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
N-[(4R,7S,8R)-5-[(2-fluorophenyl)-oxomethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
N-[(4S,7R,8S)-5-[(2-fluorophenyl)-oxomethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
N-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1,3-benzodioxole-5-carboxamide
(2S)-2-[(4R,5R)-5-[[cyclopentylmethyl(methyl)amino]methyl]-4-methyl-1,1-dioxo-8-[2-(3-pyridinyl)ethynyl]-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-5-[4-oxanyl(oxo)methyl]-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
N-[(4R,7S,8S)-5-[(2-fluorophenyl)-oxomethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
N-[(4S,7R,8R)-5-[(2-fluorophenyl)-oxomethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
N-[(4S,7S,8S)-5-[(2-fluorophenyl)-oxomethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
4-methoxy-N-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(1-oxopropyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
(3R)-2-[(R)-tert-butylsulfinyl]-4-[3-(1-cyclopentenyl)phenyl]-3-(2-hydroxyethyl)-N-(2-methoxyethyl)-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide
(3S)-2-[(S)-tert-butylsulfinyl]-4-[3-(1-cyclopentenyl)phenyl]-3-(2-hydroxyethyl)-N-(2-methoxyethyl)-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide
2-Amino-3-[2,3-di(octanoyloxy)propoxy-hydroxyphosphoryl]oxypropanoic acid
2-Amino-3-[(3-heptanoyloxy-2-nonanoyloxypropoxy)-hydroxyphosphoryl]oxypropanoic acid
2-Amino-3-[(3-butanoyloxy-2-dodecanoyloxypropoxy)-hydroxyphosphoryl]oxypropanoic acid
2-Amino-3-[(2-decanoyloxy-3-hexanoyloxypropoxy)-hydroxyphosphoryl]oxypropanoic acid
2-Amino-3-[hydroxy-(3-propanoyloxy-2-tridecanoyloxypropoxy)phosphoryl]oxypropanoic acid
2-Amino-3-[hydroxy-(3-pentanoyloxy-2-undecanoyloxypropoxy)phosphoryl]oxypropanoic acid
3-[(3-Acetyloxy-2-tetradecanoyloxypropoxy)-hydroxyphosphoryl]oxy-2-aminopropanoic acid
1,2-dioctanoyl-sn-glycero-3-phosphoserine
A 3-sn-phosphatidyl-L-serine in which the two phosphatidyl acyl groups are specified as octanoyl.
Sulfoglycolithocholate(2-)
A steroid sulfate oxoanion and N-acylglycinate that is the dianion of sulfoglycolithocholic acid arising from deprotonation of carboxylic acid and sulfate functions; major species at pH 7.3.
Upidosin
Upidosin (Rec 15/2739) is an α-1 adrenoceptor (α-1 AR) antagonist. Upidosin shows moderate selectivity for the α-1A AR subtype. Upidosin shows uroselectivity in urethra and prostate with a Kb value of 2-3 nM higher than in ear artery and aorta with a Kb value of 20-100 nM. Upidosin inhibits [3H]prazosin binding to cloned human α-1A adrenergic receptor. Upidosin can be used for the research of urethral obstruction[1].